In hepatocellular carcinoma, β-estradiol (E2) activates PPARγ in cancer cells, and activated PPARγ inhibits cell invasion by upregulating the expression of PAI-1 (Pang et al., 2013). Here, PPARG is linked to hepatocellular carcinoma.